Methylene blue used in the treatment of refractory shock resulting from drug poisoning

Clinical Toxicology

Volumn 52, Issue 1, 2014, Pages 63-65

  Fisher, Julia ^a,b   Taori, G ^c   Braitberg, G ^a,b   Graudins, A ^a,b  

^a SOUTHERN HEALTH   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c DANDENONG HOSPITAL   (Australia)

Author keywords

Methylene blue; Overdose; Poisoning; Quetiapine; Shock; Vasoplegia

Indexed keywords

ACTIVATED CARBON; ADRENALIN; CARBAMAZEPINE; DOPAMINE; FLUOXETINE; METARAMINOL; METHYLENE BLUE; NORADRENALIN; OXAZEPAM; QUETIAPINE; VALPROIC ACID; VASOPRESSIN;

ADULT; ARTICLE; ASPIRATION PNEUMONIA; CASE REPORT; COMATOSE PATIENT; CONTINUOUS INFUSION; DRUG INTOXICATION; ECHOCARDIOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; INTUBATION; MALE; NASOGASTRIC TUBE; SHOCK; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 84892145692     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2013.870343     Document Type: Article

References (13)

1. Kwok E SH, Howes D. Use of methylene blue in sepsis: a systematic review. J Intensive Care Med 2006; 21: 359-363.
2. Levin RL, Degrange MA, Bruno GF, Del Mazo CD, Taborda DJ, Griotti JJ, Boullon FJ. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg 2004; 77: 496-499.
3. Mayer B, Brunner F, Schmidt K. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 1993; 45: 367-374.
4. Bosoy D, Axelband J, Pursell RN, Lukaszczyk JJ, Stawicki SP. Utilization of methylene blue in the setting of hypotension associated with concurrent renal and hepatic failure: a concise review. OPUS 12 Scientist 2008; 2: 21-29.
5. Buzato M A, Viaro F, Piccinato C E, Evora P R. The use of methylene blue in the treatment of anaphylactic shock induced by compound 48/80: experimental studies in rabbits. Shock 2005; 23: 582-587.
6. Burns, MJ. The pharmacology and toxicology of atypical antipsychotic agents. Clin Toxicol 2001; 39: 1-14.
7. Weiner MM, Lin HM, Danforth D, Rao S, Hosseinian L, Fischer GW. Methylene blue is associated with poor outcomes in vasoplegic shock. J Cardiothorac Vasc Anesth. 2013; 27: 1233-1238. doi:10.1053/j. jvca.2013.02.026.
8. Jang D H, Nelson L S, Hoffman R S. Methylene blue in the treatment of refractory shock from an amlodipine overdose. Ann Emerg Med 2011; 58: 565-567.
9. Kim H, Hoffman R, Nelson L, Jang D. Methylene blue for refractory hypotension in cardiovascular drug overdose (Abstract 348). Abstracts of the 2012 International Congress of the European Association of Poisons Centres and Clinical Toxicologists, 25 May-1 June 2012, London, UK. Clin Toxicol 2012; 50: 273-366.
10. Aggarwal N, Kupfer Y, Seneviratne C, Tessler S. Methylene blue reverses recalcitrant shock in ® -blocker and calcium channel blocker overdose. BMJ Case Rep 2013. doi:10.1136/bcr-2012-007402.
11. Westerbergh J, Hojer J. Metformin-induced refractory vasodilatory shock successfully treated with methylene blue. (Abstract 252). Abstracts of the 2013 International Congress of the European Association of Poisons Centres and Clinical Toxicologists, Copenhagen, Denmark. Clin Toxicol 2013; 51:364.
12. Hawkins D J, Unwin P. Paradoxical and severe hypotension in response to adrenaline infusions in massive quetiapine overdose. Crit Care Resusc 2008; 10: 320-322.
13. Ng BK, Cameron AJ, Liang R, Rahman H. Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review. Can J Anesth 2008; 55: 36-41.